NCT07145255View on ClinicalTrials.gov

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2029

Study Completion Date

December 30, 2029

Conditions

Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal CancerLung Cancer (Non-Small Cell)Pancreas Cancer, Duct Cell Adenocarcinoma

Interventions

DRUG

ADC

MBRC-201 ADC

Trial Locations (3)

49546

START, Midwest, Grand Rapids

78229

START San Antonio, San Antonio

84119

START, Mountain Region, West Valley City